Skip to main navigation Skip to search Skip to main content

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV

  • Marissa Wilck
  • , Shaun Barnabas
  • , Kulkanya Chokephaibulkit
  • , Avy Violari
  • , Pope Kosalaraksa
  • , Svitlana Yesypenko
  • , Iryna Chukhalova
  • , Ron Dagan
  • , Peter Richmond
  • , Elena Mikviman
  • , Leslie Morgan
  • , Kristen Feemster
  • , Robert Lupinacci
  • , Joseph Chiarappa
  • , Shabir A. Madhi
  • , Kara Bickham
  • , Luwy Musey

Research output: Contribution to journal › Article › peer-review

4   Link opens in a new tab Citations (Web of Science)

Fingerprint

Dive into the research topics of 'A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology